NCT04853849 (MOTIVATION) is a clinical trial in Overactive Bladder, sponsored by Renalis.

Who is sponsoring NCT04853849?

NCT04853849 is sponsored by Renalis.

What condition does NCT04853849 study?

NCT04853849 studies Overactive Bladder, Urge Incontinence, Pelvic Floor Disorders.

Is NCT04853849 still recruiting?

NCT04853849 is currently status unknown. Last updated 10 December 2021.

Last reviewed 2021-12-10 · How we verify

NCT04853849: MOTIVATION

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Overactive Bladder With a Digital Conversational Agent: the MOTIVATION Study

Status unknown Last updated 10 December 2021

What this trial tests

trial in Overactive Bladder in 50 participants. Status unknown.

Timeline

26 August 2021

Primary endpoint
30 April 2022

30 April 2024

Quick facts

Lead sponsor	Renalis
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	26 August 2021
Primary completion	30 April 2022
Estimated completion	30 April 2024
Sites	1 location across United States

Conditions studied

Overactive Bladder — all drugs for Overactive Bladder →
Urge Incontinence — all drugs for Urge Incontinence →
Pelvic Floor Disorders — all drugs for Pelvic Floor Disorders →

Sponsor

Renalis

Who can join

40 and older, female only, with Overactive Bladder or Urge Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a proof of concept study for a digital therapeutic designed to provide first-line behavioral modification therapy for overactive bladder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Overactive Bladder

Currently open trials in the same condition.

NCT06201013 — Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet · NA · recruiting
NCT05895045 — Yoga for Treatment of Overactive Bladder in Pediatric Patients · NA · recruiting
NCT07209397 — Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women · NA · recruiting
NCT06921746 — Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients · recruiting
NCT06935240 — Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04853849 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Renalis
Last refreshed: 10 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04853849.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing